Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study.

Nakajima F, Morimoto S, Yurugi T, Amari Y, Kasuno Y, Fukui M, Furumatsu Y, Kitamura T.

Int J Artif Organs. 2012 Nov;35(11):981-5. doi: 10.5301/ijao.5000127.

PMID:
23065872
3.

Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.

Nakamura T, Ushiyama C, Osada S, Inoue T, Shimada N, Koide H.

J Diabetes Complications. 2003 Nov-Dec;17(6):349-54.

PMID:
14583180
4.

Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.

Nakamura T, Kawagoe Y, Matsuda T, Takahashi Y, Sekizuka K, Ebihara I, Koide H.

Kidney Blood Press Res. 2003;26(3):185-91.

PMID:
12886046
5.

Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease.

Kamimura M, Matsuo M, Miyahara T, Kimura K, Matsumoto K, Nakaya T, Abe T, Akizawa T.

Ther Apher. 2002 Dec;6(6):467-70.

PMID:
12460413
6.

LDL apheresis in atherosclerotic disease with hyperlipidemia.

Naganuma S, Agishi T, Ota K.

ASAIO J. 1992 Jul-Sep;38(3):M436-9.

PMID:
1457897
7.
8.

[Arteriosclerosis obliterans that was improved by LDL apheresis].

Suzuki H, Mutoh E, Kitagawa T, Kubota H, Takasugi Y.

Hokkaido Igaku Zasshi. 1993 Jan;68(1):126-31. Review. Japanese.

PMID:
8444401
9.

Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: two cases with marked alleviation of clinical symptoms.

Suzuki T, Sato Y, Niizuma S, Kushiro T, Tani S, Ishikawa K, Kajiwara N, Kanmatsuse K, Ikeda H, Takahashi M, Kojima S.

J Clin Apher. 2007;22(5):287-91.

PMID:
17610290
10.

Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.

Utsumi K, Kawabe M, Hirama A, Ueda K, Kamada Y, Arii K, Komaba Y, Katsura K, Iino Y, Katayama Y.

Clin Chim Acta. 2007 Feb;377(1-2):198-200. Epub 2006 Oct 6.

PMID:
17126824
11.
12.

Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.

Morimoto S, Yano Y, Maki K, Sawada K, Iwasaka T.

Am J Nephrol. 2007;27(6):643-8. Epub 2007 Sep 18.

PMID:
17878713
13.

Improvement of peripheral circulation by low density lipoprotein adsorption.

Agishi T, Kitano Y, Suzuki T, Miura A, Murakami J, Minagawa H, Ban K.

ASAIO Trans. 1989 Jul-Sep;35(3):349-51.

PMID:
2597479
14.

Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease.

Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Koide H.

Clin Nephrol. 2004 Jun;61(6):429-33.

PMID:
15224807
15.
16.

Cerebrovascular effects of hemodialysis in chronic kidney disease.

Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langhoff E.

J Cereb Blood Flow Metab. 2007 Nov;27(11):1861-9. Epub 2007 Apr 4.

17.

Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia.

Rubba P, Faccenda F, Di Somma S, Gnasso A, Scarpato N, Iannuzzi A, Nappi G, Postiglione A, De Divitiis O, Mancini M.

Stroke. 1993 Aug;24(8):1154-61.

18.

Marked removal of bezafibrate-induced high-density lipoprotein-cholesterol by low-density lipoprotein apheresis.

Kawano M, Kuroda Y, Terao M, Yaginuma T, Kawakami M, Kanazawa Y.

Clin Chim Acta. 2002 Apr;318(1-2):91-5.

PMID:
11880117
19.

[Regional cerebral blood flow in the acute stage with ischemic cerebrovascular disease studied by xenon-133 inhalation and single photon emission computerized tomography].

Kurokawa H, Iino K, Kojima H, Saito H, Suzuki M, Watanabe K, Kato T.

No To Shinkei. 1987 May;39(5):437-46. Japanese.

PMID:
3497656
20.

Increased cerebral blood flow in anemic patients on long-term hemodialytic treatment.

Vorstrup S, Lass P, Waldemar G, Brandi L, Schmidt JF, Johnsen A, Paulson OB.

J Cereb Blood Flow Metab. 1992 Sep;12(5):745-9.

Items per page

Supplemental Content

Write to the Help Desk